Pfizer Stock News

Significant business leaders are profiled in order to learn about the strategies utilized by profitable industries. To have a complete knowledge of the business, criteria such as technology, geography, and end-users are taken into consideration. This market research also examines

SINGAPORE, Nov. 19 (Xinhua) -- Pfizer, BioNTech and Moderna are making combined profits of 65,000 U.S. dollars every minute from their COVID-19 vaccines while the world''s poorest countries remain largely unvaccinated, local media cited AFP as reporting. The companies have sold the vast majority of their doses to rich countries, leaving low-income nations in the lurch, said the People''s Vaccine Alliance (PVA), a

The FDA has authorized Moderna Inc (NASDAQ: MRNA ) and Pfizer Inc (NYSE: PFE ) / BioNTech SE''s (NASDAQ: BNTX ) COVID-19 booster shots for all U.S. adults. The agency extended the emergency use authorization of a booster dose of the Moderna COVID-19 vaccine at the 50 µg dose level to all adults aged 18 and older. The booster dose from Pfizer is the same dosage strength as Full story available on Benzinga.com

Health Canada has approved the first COVID-19 vaccine for children aged five to 11 in Canada. Pfizer and its partner BioNTech submitted a request for

Health Canada approved the use of the Pfizer/BioNTech COVID-19 vaccine in children aged between five and 11 years, paving the way for the acceleration of the country''s vaccination campaign across …

The FDA moved to expand its emergency authorization of Pfizer''s and Moderna''s COVID-19 vaccine booster shots to all adults.

NEW HAVEN, Conn. and NEW YORK, Nov. 19, 2021 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN) and Pfizer Inc. (NYSE: PFE) announced today that updated safety and efficacy data from the Phase 1 dose escalation trial of ARV-471, a novel oral estrogen receptor (ER)-targeting PROteolysis TArgeting Chimera (PROTAC ® ) protein degrader, will be presented in a spotlight poster-discussion session at the 2021 San Antonio Breast Cancer Symposium (SABCS) on December 7-10, 2021. ARV-471 is being jointly developed by Arvinas and Pfizer for the treatment of patients with locally advanced or metastatic ER positive/human epidermal growth factor receptor 2 (HER2) negative (ER+/HER2-) breast cancer.

OTTAWA - Health Canada has approved the first COVID-19 vaccine for children aged five to 11 in Canada. Pfizer and its partner BioNTech submitted a req

Today, Health Canada has authorized the use of the Pfizer-BioNTech Comirnaty COVID-19 vaccine in children 5 to 11 years of age. This is the first COVI

Health Canada has officially approved the Pfizer-BioNTech COVID-19 vaccine for use in children ages 5-11.

Major stock markets on Wall Street traded mixed at Friday''s opening bell following the news that the Food and Drugs Administration approved both Moderna''s and the Pfizer/BioNTech COVID-19 boos

The FDA expanded emergency use for the Pfizer and Moderna Covid-19 vaccine boosters, signaling that the shots can be given to anyone aged 18 or older.

The administration of the Pfizer COVID-19 vaccines to children aged five to 11 years old has been delayed because the Ministry of Health has not been able to secure the lower vaccine dosage needed. This is according to a statement released on Thursday night on the ministrys Facebook page. It was previously communicated that the []